You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 33 No. 3, March 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (58)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Depressed 5-Hydroxyindole Levels Associated With Hyperactive and Aggressive Behavior

Relationship to Drug Response

Alan S. Greenberg, MD; Mary Coleman, MD

Arch Gen Psychiatry. 1976;33(3):331-336.


Abstract

• Monitoring of 5-hydroxyindole (5-HI) levels in blood in hyperactive institutionalized mentally retarded patients before and after drug therapy revealed depression of 5-HI levels in 83% of hyperactive patients. In these patients with low serotonin levels, elevation of 5-HI levels in blood into the normal range by administration of a variety of psychoactive agents was associated with the disappearance of the hyperkinetic syndrome. Patients who remained hyperactive continued to have low 5-HI levels. Return of hyperactivity upon withdrawal of medication in patients who were previously well controlled was associated with a fall in 5-HI levels. Adverse responses were seen in these patients when they were treated with medications usually tending to lower 5-HI levels in blood. Medications used in the treatment of hyperactivity may be classified as to whether they usually elevate, lower, or have no significant effect on 5-HI levels in blood.



Author Affiliations

From the Department of Neurology, University of Maryland Hospital, Baltimore (Dr Greenberg), and the Children's Brain Research Clinic, Washington, DC (Dr Coleman).


Footnotes

Accepted for publication Dec 4, 1975.

Reprint requests to 2419 Briarwood Rd, Baltimore, MD 21209 (Dr Greenberg).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Physical Aggression Is Associated With Preservation of Substantia Nigra Pars Compacta in Alzheimer Disease
Victoroff et al.
Arch Neurol 1996;53:428-434.
ABSTRACT  

Aggressive Behavior: From Laboratory to Clinic: Quo Vadit?
Eichelman
Arch Gen Psychiatry 1992;49:488-492.
ABSTRACT  

Fenfluramine and Dextroamphetamine Treatment of Childhood Hyperactivity: Clinical and Biochemical Findings
Donnelly et al.
Arch Gen Psychiatry 1989;46:205-212.
ABSTRACT  

A Pyridoxine-Dependent Behavioral Disorder Unmasked by Isoniazid
Brenner and Wapnir
Arch Pediatr Adolesc Med 1978;132:773-776.
ABSTRACT  

Chronic, Multiple Tics of Gilles de la Tourette's Disease: CSF Acid Monoamine Metabolites After Probenecid Administration
Cohen et al.
Arch Gen Psychiatry 1978;35:245-250.
ABSTRACT  

The Human Platelet: A Diagnostic and Research Tool for the Study of Biogenic Amines in Psychiatric and Neurologic Disorders
Stahl
Arch Gen Psychiatry 1977;34:509-516.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.